Latest News about NASDAQ:CRSP
Recent news which mentions NASDAQ:CRSP
From News Direct
 From News Direct
 From News Direct
 From News Direct
 Tickers 
   CRSP
  
  
  From InvestorPlace
 Tickers 
   CRSP
  
  
  From InvestorPlace
 
   3 Safe Biotech Stocks to Buy This Week
   
  
  November 24, 2023
  From StockNews.com
 
   CRSP Stock Alert: Can CRISPR Therapeutics Short Squeeze Higher?
   
  November 01, 2023
  Tickers 
   CRSP
  
  
  From InvestorPlace
 
   CRSP Stock Halt: CRISPR Trading Halted Ahead of FDA Decision
   
  October 31, 2023
  Tickers 
   CRSP
  
  
  From InvestorPlace
 
   3 Biotech Stocks With Strong Value in August
   
  
  August 04, 2023
  From StockNews.com
 
   3 Biotech Stocks With 'A' POWR Ratings
   
  
  June 22, 2023
  From StockNews.com
 
   3 of the Worst Stocks on Wall Street Right Now
   
  
  April 17, 2023
  From StockNews.com
 Tickers 
   CRSP
  
  
  From InvestorPlace
 
   3 Stocks That'll Survive Any Recession
   
  
  March 31, 2023
  From StockNews.com
 From StockNews.com
 
   4 Genomics Stocks to Consider Buying After the Crash
   
  
  June 16, 2022
  From StockNews.com
 
   5 Beaten-Down Biotech Stocks Cathie Wood Loves
   
  
  April 21, 2022
  From StockNews.com
 
   CRISPR Therapeutics Is One of Today’s Best Biotech Value Investments
   
  December 09, 2021
  Tickers 
   CRSP
  
  
  From InvestorPlace
 
   CRISPR Therapeutics Is One of Today's Best Biotech Value Investments
   
  December 06, 2021
  Tags
   NASDAQ:CRSP
  
  From StockNews.com
 Tickers 
   CRSP
  
  
  From InvestorPlace
 
   Illumina vs. CRISPR: Which Genomics Stock is a Better Choice?
   
  
  August 18, 2021
  From StockNews.com
 Tickers 
   CRSP
  
  
  From InvestorPlace
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
